Archives of Dermatology 1984-12-01

Topical v systemic agent treatment for papulopustular acne. A cost-effectiveness analysis.

R S Stern, T M Pass, A L Komaroff

Index: Arch. Dermatol. 120 , 1571-1578, (1984)

Full Text: HTML

Abstract

We used cost-effectiveness analysis to compare the costs, risks, and benefits of two strategies for clearing papulopustular acne; topical therapy alone as initial therapy or a combination of systemic antibiotics and topical agents used at the first visit. Patients treated with combination therapy had fewer weeks of morbidity from acne, and lower dollar costs but have a greater risk of side effects. If the topical therapy alone was chosen to reduce the risk of side effects in a population of patients there would be an additional $764 in costs and 238 weeks of morbidity from acne to avert a single additional instance of side effects. Initial treatment of papulopustular acne with combined oral antibiotics and topical agents thus seems to be cost-effective. After clearing is achieved, maintenance therapy with topical agents should be considered.